Safe Fertility Group Valuation
Is SAFE-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SAFE-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SAFE-R (THB22.8) is trading above our estimate of fair value (THB17.42)
Significantly Below Fair Value: SAFE-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SAFE-R?
Other financial metrics that can be useful for relative valuation.
What is SAFE-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿6.93b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.5x |
Enterprise Value/EBITDA | 19.5x |
PEG Ratio | 1.6x |
Price to Earnings Ratio vs Peers
How does SAFE-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.4x | ||
KLINIQ Klinique Medical Clinic | 28.2x | 22.6% | ฿8.1b |
GFC Genesis Fertility Center | 30.4x | 19.9% | ฿2.4b |
BKGI Bangkok Genomics Innovation | 54.9x | n/a | ฿1.8b |
D Dental Corporation | 16.1x | n/a | ฿1.1b |
SAFE-R Safe Fertility Group | 34.3x | 20.9% | ฿6.9b |
Price-To-Earnings vs Peers: SAFE-R is expensive based on its Price-To-Earnings Ratio (34.3x) compared to the peer average (32.4x).
Price to Earnings Ratio vs Industry
How does SAFE-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: SAFE-R is expensive based on its Price-To-Earnings Ratio (34.3x) compared to the TH Healthcare industry average (26.9x).
Price to Earnings Ratio vs Fair Ratio
What is SAFE-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 34.3x |
Fair PE Ratio | 30.8x |
Price-To-Earnings vs Fair Ratio: SAFE-R is expensive based on its Price-To-Earnings Ratio (34.3x) compared to the estimated Fair Price-To-Earnings Ratio (30.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.